The European Union has called for an Emergency Vaccine Summit after more than 8 European nations decided to stop using the AstraZeneca COVID-19 vaccine due to serious blood clot incidents reported in many countries.
WHISTLEBLOWER: Recent Monkeypox Strain Originated From A Lab Claims European CDC Whistleblower
EXPLOSIVE DOCUMENTS Show Wuhan Lab Recently Assembled Monkeypox Strains Creating Contagious Pathogens
BIG STORY: Genetically Modified Strain Of Monkeypox Kills 250 Million People In War Game Simulation Prompting New Pandemic Warning
The EMA (European Medicines Agency) is to hold an emergency meeting after EU states press pause on their rollouts of the AstraZeneca Covid-19 vaccine. This meeting is to hold on Thursday to think about the next move after the suspension decision taken by many EU nations.
Authorities have reported blood-clotting incidents associated with this vaccine. These incidents occurred in people who got vaccinated from one batch of million AstraZeneca doses distributed across several EU nations.
The EMA said it was looking at blood-clotting as well as reports of unusual features, such as low platelet numbers reported in a small number of recipients of the AstraZeneca jab, adding the rate of clotting incidents did not appear “to be higher than that seen in the general population.”
On Monday regulators said that the committee would look at the data on Tuesday and a meeting will be held on Thursday to decide the next move.
Subscribe to GreatGameIndia
It said that while its investigation is ongoing, it “currently remains of the view that the benefits of the AstraZeneca vaccine in preventing Covid-19, with its associated risk of hospitalization and death, outweigh the risks of side effects.”
Recently, a 65-year-old man in India collapsed and passed away just five minutes after getting first dose of vaccine against covid-19. He was injected with 0.5 ml dose of Oxford AstraZeneca vaccine Covishield intramuscularly.
Even Australia’s Health Minister Greg Hunt in charge of rolling out Australia’s coronavirus vaccine program was hospitalized just one day after taking the AstraZeneca COVID-19 vaccine.
According to a report by Germany’s Standing Vaccination Commission, the Oxford-AstraZeneca COVID-19 vaccine is only effective 8% in people over 65.
Three European countries of Sweden, France and Germany have decided not to use AstraZeneca COVID-19 vaccine for people over 65. This decision was made due to the lack of data available about its effectiveness in elderly people.
For latest updates on the outbreak check out our Coronavirus Coverage.